KAIRE HOLDINGS INC
10QSB, EX-27, 2000-11-13
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Previous: KAIRE HOLDINGS INC, 10QSB, 2000-11-13
Next: FORTIS BENEFITS INSURANCE CO, 10-Q, 2000-11-13



<TABLE> <S> <C>

<PAGE>

<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-1999
<PERIOD-END>                               SEP-30-2000
<CASH>                                         107,638
<SECURITIES>                                         0
<RECEIVABLES>                                1,072,873
<ALLOWANCES>                                         0
<INVENTORY>                                    290,000
<CURRENT-ASSETS>                             1,535,928
<PP&E>                                         252,581
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                               5,603,510
<CURRENT-LIABILITIES>                        1,776,881
<BONDS>                                              0
                                0
                                          0
<COMMON>                                       116,653
<OTHER-SE>                                   3,709,976
<TOTAL-LIABILITY-AND-EQUITY>                 3,826,629
<SALES>                                              0
<TOTAL-REVENUES>                             2,017,966
<CGS>                                        1,341,252
<TOTAL-COSTS>                                  646,570
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               1,551
<INCOME-PRETAX>                                 28,593
<INCOME-TAX>                                       400
<INCOME-CONTINUING>                             28,193
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    28,193
<EPS-BASIC>                                          0
<EPS-DILUTED>                                        0


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission